October 14, 2024

Understanding the Therapeutic Potential of GT-02287 in GBA-Parkinson Disease

Jonas Hannestad, MD, PhD, chief medical officer at Gain Therapeutics, provided clinical perspective on promising data from a phase 1 first-in-human study of GT-02287, an investigational therapy for Parkinson disease with or without a GBA1 mutation.

October 14, 2024

New tech helps Norton Healthcare treat Parkinson’s tremors with non-invasive procedure – WDRB

October 14, 2024

Heuron gets certification of its AI solution to diagnose Parkinson’s disease – KBR

October 14, 2024

Brain Molecule Ophthalmic Acid Reverses Parkinson’s Movement Deficits, UC Irvine Study Finds – ScienceBlog.com

October 14, 2024

CBS Miami’s Ted Scouten talks about stress impacting Parkinson’s symptoms – CBS Miami